Diddy, you wrote, "Do we think we will be selling billions of dollars worth of Leronlimab for COVID in 2051? A 30x multiple would require it. And, while we expect to have many more indications approved by then, a 30x multiple isn't reasonable until we have said approvals."

I tend to think you mean 2021 instead of 2051. 2051 is a misty place beyond the veil. So are we going to be selling billions of dollars for Covid in 2021? Yes, the vaccines will wear off, and the virus will mutate, and the LH trial should be a success too. I also believe that doctors will realize that Leron can be enormously helpful for moderate patients as well. You want to prevent them from becoming severe, keep them out of the hospital? Give a moderate a shot. Offlabel maybe, but I think it will happen. (If I had moderate Covid, I'd pay $3000 immediately if I knew it could prevent me from becoming severe.)